FDA Investigator Massoud Motamed

Massoud Motamed has conducted inspections on 51 sites in 7 countries as of 07 Aug 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
51
Last Inspection Date:
07 Aug 2017
Investigator Role:
FDA Investigator
Redica ID:
100000362
Countries of Inspections:
India, China, United States of America, Austria, Spain, Switzerland, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Massoud Motamed:
Aaron L Dunbar, Abdollah Koolivand, Adam C Hipko, Ademola O Daramola, Adrian Rodriguez, Alberto A Viciedo, Alicia M Mozzachio, Alison N Stieg, Anastasia I Onuorah, Anastasia M Shields, Andrea A Branche, Angela E Glenn, Angela Mock, Ann L Demarco, Anthony A Charity, Arie R Dyk, Ariel Cruz Figueroa, Arsen Karapetyan, Atul J Agrawal, Azza Talaat, Barbara J Rincon, Bill Tacket, Jr, Bing Lin, Bonita S Chester, Brackens Harris, Brandon K Barbee, Brian D Nicholson, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Camerson E Moore, Carol A Declouette Wilburn, Casey L Hamblin, Cathleen A Castellaw, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chad J Whitwell, Chaltu Nwakijra, Charles B Steinmiller, Charles D Brown, Cheryl A Clausen, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher L Jacobs, Christopher S Keating, Claire M Minden, Crystal S Harris, Dallas E Gilbreath Jr, Dana M Lewis, Daniel J Lahar, Daniel J Roberts, Danielle Lyke, Danny D Horner, Darla J Christopher, David M Beltran, Debra D Devlieger, Denise Connelly, Dennis Cantellops Paite, Dennis L Doupnik, Diane L Raccasi, Diane T Bargo, Diane T O'brien, Dipesh K Shah, Douglas A Campbell, Dr. Carmelo Rosa, Edmund F Mrak, Jr, Edward D Edmiston, Elizabeth D Connell, Elmina E Akwo, Elmina E Mboh, Emest F Bizjak, Eric M Mueller, PharmD, Erika V Butler, Farhana Khan, Felix Maldonado, Franklin R Harris, Frans E Mercado, Gam S Zamil, George Pyramides, Gery M Duparc, Grant L Davis, Guerlain Ulysse, Guo Q Shen, Gwyn G Dickinson, H Ljamilla Selby, Habacuc V Barrera, Haijing Hu, Hala L Selby, Hung V Le, J Elkins, James L Dunnie, Jr, James M Mason, Jamie M Bumpas, Janet A Rajan, Janice M Hickok, Jay V Jariwala, Jeffrey P Raimondi, Jeffrey R Wooley, Jennifer Lalama, Jennifer O Dowdy, Jodi M Gatica, Joel D Hustedt, Jogy George, Johann M Fitch, John P Mistler, Johnna L Bleem, Jonaida Estevez Martinez, Jonathan A Womack, Jonathan W Chapman, Jose Acruz Gonzalez, José E Meléndez, Jose Martinez, Jr, Joseph E Duran, June P Page, Justin A Boyd, Kamara Tx, Karen C Daugherty, Karlton T Watson, Katelyn Astaub Zamperini, Katherine E Jacobitz, Katherine Szestypalow, Kathleen Chmura Shaffer, Kellia N Hicks, Kenitra D Hewitt, Kevin A Gonzalez, Kevin D Kallander, Kevin T Nguyen, Kham Phommachanh, Kimberley A Hoefen, Ko U Min, Kshitij A Patkar, L Grant, Lance Sindo, CIH, CQA, RS, Lata C Mathew, PhD, Latorie S Jones, Laurie B Frazier, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Chad N Thompson, Liming Zhang, Linda F Murphy, Lisa L Flores, Lisa M Puttonen, Lisa M Yoder, Lisa R Jennings, Lisa R Whitt, Lloyd D Payne, Loan T Tran, Lori G Cantin, Lorie S Hannappel, Lourdes R Genera, Lucas B Leake, Mada A Tautges, Makini Cobourne Duval, PhD, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Annes, Martha S Baldwin, Matthew R Maddox, Matthew R Sleeter, Melissa J Garcia, Melissa T Roy, Michael A Charles, Michael A Taylor, Michael L Jones, Michelle Marsh, Monique Rac Lester, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Munizn, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Navista C Bolton, Nimmy Mathews, Pankaj H Amin, Parul M Patel, Patrice S Hall, Patty P Kaewussdangkul, Paul A Bonneau, Paul E Frazier, Paula J Bretz, Peter E Baker, Philip M Steele, PhD, Pratik S Upadhyay, DDC, Priya J Rathnam, Qin Xu, Rabin N Ghoshal, Rafael E Arroyo, Rafeeq A Habeeb, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Rita K Kabaso, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert T Lorenz, Saleem A Akhtar, Sandy J Ziegler, Sangeeta M Khurana, PhD, Sara Rothman, Sarah Forney, Satheesh Thomas, Scott T Ballard, Sean R Marcsisin, Seri L Essary, Sha'tina R Alridge, Shanna N Purdy, Sharon K Thoma, PharmD, Shelby N Turner, Sherrie L Krolczyk, Simone E Pitts, Sneha S Patel, Staci G Mcallister, Stefanie L Heckman, Stefanie L Kremer, Stephen D Brown, Stephen D Eich, Stephen L Beekman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Suzanne N Vallez, Tamera H Hunt, Tamika White, Tamil Arasu, PhD, Tara A Gray, Tara G Bizjak, Thomas J Arista, Toby Vern H Hill, Tomika L Bivens, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Tricia S Martinez, Trina K Vick, Truong Xuan Nguyen (Andy), Tsedenia Woldehanna, Unnee Ranjan, Vilmary Negron Rodriguez, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, William A Warnick, William L Bargo, Xiaokuang Lai, PhD, Yvins Dezan

Massoud Motamed's Documents

Publish Date Document Type Title
June, 2017 FDA 483 Cantrell Drug Company - Form 483, 2017-06-29
May, 2016 FDA 483 Interquim, S.A. - Form 483, 2016-05-06
December, 2015 FDA 483 SOFTECH PHARMA PRIVATE LIMITED - Form 483, 2015-12-11
February, 2016 FDA 483 I.V. Specialty, Ltd - Form 483, 2016-02-05
February, 2016 FDA 483 CTX Lifesciences Pvt. Ltd. - Form 483, 2016-02-19
October, 2015 FDA 483 Response Goodier Cosmetics - Form 483R, 2015-10-28
July, 2015 FDA 483 Allergan Sales, LLC - Form 483, 2015-07-10
October, 2015 EIR Goodier Cosmetics - EIR, 2015-10-08
July, 2016 FDA 483 US Compounding Inc - Form 483, 2016-07-15
February, 2017 FDA 483 Preferred Homecare (Park Infusioncare LP) - Form 483, 2017-02-17
November, 2016 FDA 483 Response Mylan Pharmaceuticals Inc. - Form 483R, 2017-02-13
April, 2015 FDA 483 B & P Industrial Inc. - Form 483, 2015-04-01
January, 2017 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2017-01-30
May, 2017 EIR Zhejiang Huahai Pharmaceutical Co., Ltd. - EIR, 2017-05-19
March, 2016 FDA 483 Response AstraZeneca Pharmaceuticals LP - Form 483R, 2016-04-19
November, 2015 FDA 483 Mary Kay, Inc - Form 483, 2015-11-17
July, 2015 EIR Allergan Sales, LLC - EIR, 2015-07-10
September, 2016 FDA 483 Megafine Pharma (P) Limited - Form 483, 2016-09-23
April, 2016 FDA 483 Purac BioQuimica, S.A. - Form 483, 2016-04-21
June, 2015 FDA 483 Vita Pharmacy, LLC dba Talon Compounding Pharmacy - Form 483, 2015-06-24
June, 2016 FDA 483 Laboratoire Sintyl S.A. - Form 483, 2016-06-23
May, 2017 FDA 483 Shandong Vianor Biotech Co., Ltd. - Form 483, 2017-05-10
January, 2017 FDA 483 Response AstraZeneca Pharmaceuticals LP - Form 483R, 2017-02-10
October, 2016 FDA 483 Allergan Sales, LLC - Form 483, 2016-10-28
July, 2016 FDA 483 Bachem SA, Succursale de Vionnaz - Form 483, 2016-07-01
October, 2016 EIR Allergan Sales, LLC - EIR, 2016-10-28
December, 2015 FDA 483 Pan Drugs Limited - Form 483, 2015-12-03
October, 2015 FDA 483 Goodier Cosmetics - Form 483, 2015-10-08
December, 2016 FDA 483 Hetero Labs Limited - Form 483, 2016-12-16
August, 2017 FDA 483 Emcure Pharmaceuticals Limited - Form 483, 2017-08-17
May, 2015 FDA 483 Response Blue Bell Creameries, L.P. - Form 483R, 2015-05-22
August, 2017 FDA 483 BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED - Form 483, 2017-08-04
September, 2016 FDA 483 Mylan Laboratories Limited - Form 483, 2016-09-14
December, 2016 FDA 483 DIVI'S LABORATORIES LIMITED - Form 483, 2016-12-06
December, 2016 EIR Hetero Labs Limited - EIR, 2016-12-16
May, 2017 FDA 483 Zhejiang Huahai Pharmaceutical Co., Ltd. - Form 483, 2017-05-19
March, 2016 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2016-03-29
January, 2017 FDA 483 Fujifilm Ultra Pure Solutions Inc. - Form 483, 2017-01-12
July, 2016 FDA 483 US Compounding Inc - Form 483, 2015-08-21
May, 2017 FDA 483 Bicooya Cosmetics Limited - Form 483, 2017-05-25
November, 2016 EIR Mylan Pharmaceuticals Inc. - EIR, 2016-11-18
November, 2016 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2016-11-18
May, 2015 FDA 483 Blue Bell Creameries, L.P. - Form 483, 2015-05-01

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more